Which ETFs hold Johnson & Johnson (JNJ)?
American healthcare giant making prescription medicines and medical devices for surgery and hearts.
38 Australian ETFs hold Johnson & Johnson, a Health Care company from United States. DRUG has the biggest weighting at 7.60%. Across these funds, Australian ETF investors own about $1.1bn of Johnson & Johnson.
The ETFs with the most Johnson & Johnson
All 38 ETFs that hold Johnson & Johnson, ranked by weight
Best-endeavours estimate. Built from each issuer's published holdings, which may be weeks or months old, may cover only part of a fund (some publish only their top 10) and are matched by company name. Figures may be incomplete or inaccurate. Check the issuer's website and PDS before relying on them. General information only.
Weights from each issuer's published holdings (September to November 2026). Some funds list only their largest holdings. General information only, not a recommendation to buy or sell Johnson & Johnson.
Common questions
Which ETF has the most Johnson & Johnson?
DRUG (Betashares Global Healthcare Currency Hedged ETF) has the highest weighting, with 7.60% of the fund in Johnson & Johnson.
What is the cheapest ETF that holds Johnson & Johnson?
Of the ETFs where Johnson & Johnson is at least 1% of the fund, IVV has the lowest fee at 0.04% a year, with 1.01% in Johnson & Johnson.
How much Johnson & Johnson do I own with $10,000 in VGS?
About $70. VGS is the largest ETF that holds Johnson & Johnson, and Johnson & Johnson makes up 0.70% of it.
How many Australian ETFs hold Johnson & Johnson?
38 ETFs listed on the ASX or TMX Australia hold Johnson & Johnson, based on issuers' published holdings.